Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW)

CUSIP: 68236X118

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 99/99/999
Total 13F shares
3,714,971
Share change
+3,589,971
Total reported value
$2,563,785
Price per share
$0.69
Number of holders
21
Value change
+$2,477,785
Number of buys
20

Quarterly Holders Quick Answers

What is CUSIP 68236X118?
CUSIP 68236X118 identifies TOIIW - Oncology Institute, Inc. - *W EXP 99/99/999 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) as of Q4 2021

As of 31 Dec 2021, Oncology Institute, Inc. - *W EXP 99/99/999 (TOIIW) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,714,971 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), HIGHBRIDGE CAPITAL MANAGEMENT LLC, Davidson Kempner Capital Management LP, Jefferies Group LLC, DIFESA CAPITAL MANAGEMENT, LP, Union Square Park Capital Management, LLC, WOLVERINE ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, Man Group plc, and HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.